ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Endoscopic Thoracic Sympathectomy in the Treatment of Vasospastic Angina Resistant to Medical Therapy [Anatol J Cardiol]
Anatol J Cardiol. 2024; 28(1): 29-34 | DOI: 10.14744/AnatolJCardiol.2023.3484

Endoscopic Thoracic Sympathectomy in the Treatment of Vasospastic Angina Resistant to Medical Therapy

Mustafa Azmi Sungur1, Gönül Zeren1, Mehmet Fatih Yılmaz1, İlhan İlker Avcı1, Fatma Can1, Tuğba Çetin1, Aylin Sungur2, Ozan Tezen1, Enver Yücel3, Ali Karagöz3, Tamer Okay4, Can Yücel Karabay1
1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Research and Training Hospital, İstanbul, Türkiye
2Department of Cardiology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Türkiye
3Department of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, Türkiye
4Department of Thoracic Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Research and Training Hospital, İstanbul, Türkiye

Background: In this study, we aimed to investigate the clinical follow-up results of endoscopic thoracic sympathectomy (ETS) in the treatment of vasospastic angina (VSA) resistant to maximal medical therapy.

Methods: A total of 80 patients with VSA who presented to our hospital between 2010 and 2022 were included in our study. Among them, 6 patients who did not respond to medical therapy underwent ETS. In-hospital and long-term clinical outcomes of patients who underwent ETS were recorded.

Results: The median age of the patients with VSA was 57 [48-66] years, and 70% of the group were males. In the ETS group, compared to the non-ETS group, higher numbers of hospital admissions and coronary angiographies were observed before ETS (median 6 [5-6] versus 2 [1-3], P <.001; median 5 [3-6] versus 2 [1-3], P =.004, respectively). Additionally, while 2 patients (33.3%) in the ETS group had implantable cardioverter defibrillator (ICD), only 2 patients (2.7%) in the non-ETS group had ICD (P =.027). Out of the 6 patients who underwent ETS, 2 were females, with a median age of 56 [45-63] years. Four patients underwent successful bilateral ETS, while 2 patients underwent unilateral ETS. During the follow-up period after ETS, only 3 patients experienced sporadic attacks (once in 28 months, twice in 41 months, and once in 9 years, respectively), while no attacks were observed in 3 patients during their median follow-up of 7 years.

Conclusion: It appears that ETS is effective in preventing VSA attacks without any major complications.

Keywords: Vasospastic angina, endoscopic thoracic sympathectomy, cardiac sympathetic denervation

Mustafa Azmi Sungur, Gönül Zeren, Mehmet Fatih Yılmaz, İlhan İlker Avcı, Fatma Can, Tuğba Çetin, Aylin Sungur, Ozan Tezen, Enver Yücel, Ali Karagöz, Tamer Okay, Can Yücel Karabay. Endoscopic Thoracic Sympathectomy in the Treatment of Vasospastic Angina Resistant to Medical Therapy. Anatol J Cardiol. 2024; 28(1): 29-34

Corresponding Author: Mustafa Azmi Sungur
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.